AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11566459
Drug: Ketoprofen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (200 mg daily) with aspirin (325 mg daily)
Trial: 11566459
Drug: Ketoprofen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (200 mg daily) without aspirin
Trial: 7825702
Drug: Functional meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional meal preparation group (n = 23)
Trial: 3373080
Drug: Dapsone (DDS)
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dapsone (DDS) injection
Trial: 3373080
Drug: Monoacetyldapsone (MADDS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoacetyldapsone (MADDS) injection
Trial: 29024079
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide 5% gel or cream
Trial: 16574999
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of cisplatin in course 1
Trial: 16574999
Drug: BSA-adjusted dose
RxNorm normalized name: Fmlt bsasm h
DrugBank: Honokiol (DB19283)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BSA-adjusted dose of cisplatin in course 2
Trial: 15389743
Drug: Actual laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actual laser therapy (LLLT)
Trial: 19876045
Drug: Placebo laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo laser therapy
Trial: 3817031
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (high doses, orally administered)
Trial: 31114155
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination (FDC) of amlodipine 10 mg/olmesartan 40 mg/rosuvastatin 20 mg
Trial: 31114155
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of FDC (amlodipine 10 mg/olmesartan 40 mg) and rosuvastatin 20 mg
Trial: 20491709
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g EPA for 15 weeks
Trial: 11948003
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg ER
Trial: 11948003
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg ER
Trial: 11948003
Drug: ER formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ER formulation
Trial: 11948003
Drug: Higher ER
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher ER doses
Trial: 7053922
Drug: Frusemide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (1 mg/kg)
Trial: 7053922
Drug: Chlorthiazid (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthiazid (10 mg/Kg)
Trial: 7053922
Drug: Frusemide (0.25‐0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (0.25‐0.5 mg/Kg)
Trial: 7053922
Drug: Chlorthiazid (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthiazid (20 mg/Kg)
Trial: 31374063
Drug: 0.05% cyclosporine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% cyclosporine ophthalmic emulsion (CsA OE)
Trial: 26149189
Drug: l-carnitine 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-carnitine 750 mg/d for 8 weeks
Trial: 21659360
Drug: Fludarabine, Chlorambucil,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine, Chlorambucil, and Fludarabine with Cyclophosphamide as first-line treatment
Trial: 12013322
Drug: Cardiovascular agents
RxNorm normalized name: CARDIOVASCULAR AGENTS,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiovascular agents
Trial: 9864106
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion under the right hemidiaphragm (Group B)
Trial: 9864106
Drug: Bupivacaine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 1.5 mg/kg infusion under the right hemidiaphragm (Group C)
Trial: 9864106
Drug: Bupivacaine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine infusion with subhepatic drain (Group D)
Trial: 9864106
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline plus bupivacaine infusion (Group E)
Trial: 7016242
Drug: Lateral subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral subcutaneous sphincterotomy under general anaesthesia (n = 37)
Trial: 7016242
Drug: Lateral subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral subcutaneous sphincterotomy under local anaesthesia (n = 34)
Trial: 28954570
Drug: Solution-Focused Brief
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Solution-Focused Brief Couple Therapy (SFBCT)
Trial: 25102328
Drug: Naltrexone (NTX)
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone (NTX) 25 mg/d for 8 weeks
Trial: 21925716
Drug: AZD0837 (150,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD0837 (150, 250 or 350 mg)
Trial: 21925716
Drug: ximelagatran (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ximelagatran (36 mg twice daily)
Trial: 21925716
Drug: Vitamin K
RxNorm normalized name: Vitamin K
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K antagonist (VKA) titrated to INR of 2-3
Trial: 20806988
Drug: Guanfacine XR
RxNorm normalized name: guanfacine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine XR (1-4 mg/day)
Trial: 12735532
Drug: Home therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home therapy
Trial: 2180271
Drug: Cisplatin 100
RxNorm normalized name: CISPLATIN 100MG/VIL (PF) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 100 mg/m2 alone (group I)
Trial: 2180271
Drug: Cisplatin 100
RxNorm normalized name: CISPLATIN 100MG/VIL (PF) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 100 mg/m2 and oral disulfiram 2000 mg/m2 (group II)
Trial: 31069935
Drug: Insulin aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin aspart (IAsp) (0.3 U/kg)
Trial: 26502953
Drug: Rhodiola rosea
RxNorm normalized name: RHODIOLA ROSEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhodiola rosea L (2 × 200 mg dose Vitano®, 1 tablet taken before breakfast and 1 tablet before lunch)
Trial: 15380963
Drug: Invasive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Invasive treatment (angiography and intervention within 24 hours of thrombolysis)
Trial: 9694317
Drug: Interval training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interval training at ventilatory threshold (Vth), walking/jogging sessions twice a week, duration increased from 30 min to 1 h over 3 months
Trial: 8589465
Drug: 10% low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% low molecular weight dextran at 25 mL/hr
Trial: 2760258
Drug: Norfloxacin (NOR)
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin (NOR) 800 mg/d
Trial: 2760258
Drug: Ciprofloxacin (C)
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (C) 1 g/d
Trial: 2760258
Drug: Nalidixic acid
RxNorm normalized name: Nalidixic Acid
DrugBank: Nalidixic acid (DB00779)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nalidixic acid (NAL) 2 g/d
Trial: 29796671
Drug: Monosodium glutamate
RxNorm normalized name: Monosodium Glutamate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monosodium glutamate (MSG) supplemented vegetable broth (3.8 g MSG daily for 4 weeks)
Trial: 30207748
Drug: Technosphere insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Technosphere insulin (TI)
Trial: 26180109
Drug: Insulin aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin aspart (C)
Trial: 22181827
Drug: QS ruby
RxNorm normalized name: Ruby arsenic
DrugBank: Tetraarsenic tetrasulfide (DB19141)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QS ruby laser, aggressive treatment (Group 1)
Trial: 22181827
Drug: QS ruby
RxNorm normalized name: Ruby arsenic
DrugBank: Tetraarsenic tetrasulfide (DB19141)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QS ruby laser, mild treatment (Group 2)
Trial: 22181827
Drug: QS frequency
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: QS frequency doubled Nd:YAG laser, aggressive treatment (Group 3)
Trial: 22181827
Drug: QS frequency
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: QS frequency doubled Nd:YAG laser, mild treatment (Group 4)
Trial: 20962614
Drug: Interferon‐α administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon‐α administration during structured treatment interruptions (STIs)
Trial: 17459295
Drug: Topical diflucortolone
RxNorm normalized name: diflucortolone Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diflucortolone valerate 0.001 percent and oral cetirizine hydrochloride (Group A)
Trial: 17459295
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin in addition to topical diflucortolone valerate and oral cetirizine hydrochloride (Group B)
Trial: 17459295
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone or intralesional triamcinolone acetonide (for severe cases)
Trial: 8927677
Drug: Nicotine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (7 mg/day for nonsmokers and 21 mg/day for smokers)
Trial: 1642023
Drug: Diet and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet and/or oral antidiabetics
Trial: 26115881
Drug: HCV treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV treatment
Trial: 11113401
Drug: Pravastatin (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (combined with cholestyramine and/or nicotinic acid) to achieve LDL cholesterol levels of < or =130 mg/dl (group A)
Trial: 11113401
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (group B) with antilipidemic therapy determined by family physicians
Trial: 11113401
Drug: Pravastatin-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin-based therapy (group A)
Trial: 3297472
Drug: Caffeine 360
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine 360 mg
Trial: 3297472
Drug: Caffeine >90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine >90 mg
Trial: 3297472
Drug: Caffeine (dose-related)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (dose-related)
Trial: 3297472
Drug: Caffeine (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (not dose-related)
Trial: 31327670
Drug: Aerosolized 15%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized 15% xylitol (5 ml) twice a day for 14 days
Trial: 31327670
Drug: Aerosolized 7%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized 7% hypertonic saline (4 ml) twice a day for 14 days
Trial: 29211295
Drug: FOLFOX/Bev (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFOX/Bev (for TS-L tumors)
Trial: 27350298
Drug: Control (conservative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (conservative treatment)
Trial: 23163143
Drug: Comprehensive protocol
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive protocol of integrative medicine (naomai jiejing decoction No. 1 and No. 2)
Trial: 23163143
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy and nimodipine (control group)
Trial: 18032857
Drug: Oral terbinafine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbinafine 250 mg, one tablet twice daily for seven days every month (pulse therapy)
Trial: 18032857
Drug: Oral terbinafine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbinafine pulse therapy plus topical ciclopirox olamine 8% applied once daily at night
Trial: 18032857
Drug: Oral terbinafine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbinafine pulse therapy plus topical amorolfine hydrochloride 5% applied once weekly at night
Trial: 16151607
Drug: KTP 532-nm
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KTP 532-nm laser treatment with pulse duration (PD) varying from 0.13 to 1.71 times thermal relaxation time (Tr)
Trial: 16151607
Drug: KTP 532-nm
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KTP 532-nm laser treatment with PD near or higher than Tr
Trial: 11967748
Drug: Ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.2% with sufentanil 2 microgram/ml
Trial: 11967748
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% with sufentanil 2 microgram/ml
Trial: 1428294
Drug: Gallopamil 50
RxNorm normalized name: gallopamil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallopamil 50 mg single-dose
Trial: 1428294
Drug: Gallopamil 50
RxNorm normalized name: gallopamil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallopamil 50 mg steady-state (after nine doses)
Trial: 12766522
Drug: Implantable cardioverter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter defibrillator (ICD) therapy
Trial: 15294263
Drug: No ICD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ICD therapy
Trial: 26490053
Drug: No antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotics (no-antibiotic group)
Trial: 17664372
Drug: In-treatment LV
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment LV hypertrophy absence (measured by CP and SLV)
Trial: 17664372
Drug: In-treatment LV
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment LV hypertrophy absence (measured by SLV)
Trial: 17664372
Drug: In-treatment LV
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment LV hypertrophy absence (measured by CP)
Trial: 17664372
Drug: Absence of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Absence of in-treatment LV hypertrophy (by both SLV and CP)
Trial: 6382987
Drug: Acebutolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (400 mg thrice daily)
Trial: 6382987
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg thrice daily)
Trial: 28789578
Drug: Accelerated intermittent
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated intermittent theta‐burst stimulation (aiTBS) treatment over the left dorsolateral prefrontal cortex (DLPFC)
Trial: 22695239
Drug: Solabegron 125
RxNorm normalized name: Solabegron
DrugBank: Solabegron (DB06190)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solabegron 125 mg
Trial: 9987165
Drug: Diphtheria antitoxin
RxNorm normalized name: Diphtheria Antitoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria antitoxin (> 0.01 IU ml‐1)
Trial: 7567643
Drug: Lactitol (250-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactitol (250-400 mg/kg/day)
Trial: 7567643
Drug: Lactulose (500-750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (500-750 mg/kg/day)
Trial: 2187272
Drug: 4 litre
RxNorm normalized name: glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 litre regimen of a solution of electrolytes and polyethylenglycol
Trial: 31455295
Drug: Remifentanil 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 0.3 μg/kg (diluted to 2 ml) 1 min before sufentanil injection
Trial: 31455295
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (NS) 2 ml at the same time point as sufentanil injection
Trial: 31455295
Drug: Remifentanil 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 0.3 μg/kg
Trial: 20889287
Drug: Mild hypothermia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild hypothermia therapy (body temperature maintained at 32.7°C for 72 hours)
Trial: 17086911
Drug: Oromucosal cannabis-based
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oromucosal cannabis-based medicine (CBM)
Trial: 15589385
Drug: Paroxetine 20
RxNorm normalized name: PARoxetine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20 mg QD
Trial: 11759100
Drug: UltraSeal XT
RxNorm normalized name: Ultrasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UltraSeal XT plus (filled sealant with drying agent)
Trial: 9263279
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine supplementation after exhaustive exercise
Trial: 11548448
Drug: Captopril (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25-50 mg b.i.d.)
Trial: 18958167
Drug: Concurrent presentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent presentation of objective information about diseases
Trial: 15723892
Drug: CBSM+ intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBSM+ intervention (10-week group cognitive-behavioral stress management/expressive supportive therapy)
Trial: 12830458
Drug: T +
RxNorm normalized name: RE PreVit + DHA Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T + V (Trandolapril 2 mg + Verapamil 180 mg)
Trial: 12830458
Drug: T +
RxNorm normalized name: RE PreVit + DHA Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T + A (Trandolapril 2 mg + Amlodipine 5 mg)
Trial: 8895271
Drug: Ketorolac 60
RxNorm normalized name: ketorolac 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 60 mg (Group II)
Trial: 6594786
Drug: Fluoride-containing sucking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride-containing sucking tablet (Fludent, 0.25 mg F) daily at bedtime for 3 years
Trial: 6594786
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no fluoride tablet)
Trial: 29071950
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (3 months duration)
Trial: 29071950
Drug: Routine rehabilitation
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine rehabilitation therapy (Control group)
Trial: 17900364
Drug: Whole milk
RxNorm normalized name: Calcium fortified whole milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole milk (710 ml daily for one month)
Trial: 17900364
Drug: Low fat
RxNorm normalized name: Low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fat (2%) milk (710 ml for one week)
Trial: 12090906
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg (R)-carvedilol
Trial: 12090906
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg (S)-carvedilol
Trial: 12090906
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg (R,S)-carvedilol
Trial: 12090906
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg (R,S)-carvedilol (in patients with essential arterial hypertension)
Trial: 7675047
Drug: DTP toxoids
RxNorm normalized name: DIPHTHERIA TOXOID
DrugBank: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP toxoids after two doses
Trial: 7029988
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 2 g/die for 30 days
Trial: 30856025
Drug: Fennel infusion
RxNorm normalized name: Fennel
DrugBank: Fennel (DB15615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fennel infusion plus dry cupping
Trial: 25172889
Drug: ET receptor
RxNorm normalized name: P2Y12 G-protein-coupled platelet receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ET receptor blockade (bosentan)
Trial: 15573192
Drug: Dexamethasone 0.5mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.5mg/kg intravenous
Trial: 26550815
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment with passive cycling (PC)
Trial: 12135314
Drug: Amlodipine (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (calcium antagonist)